Clinical trial NCT04945408: Longitudinal Description of Hemorrhoidal Pathology
Official title: Longitudinal Description of Hemorrhoidal Pathology
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Hemorrhoids
Lead sponsor: Fondation Hôpital Saint-Joseph
Sponsor class: OTHER
First posted: 2021-06-30
Enrollment: 500
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Consecutive patients consulting for hemorrhoidal disease in the proctology department of the Groupe Hospitalier Paris Saint-Joseph (GHPSJ) between January 1st 2020 and April 30th 2020

Brief summary: Hemorrhoidal disease is a common cause of gastroenterology visits. In the United States, it is considered the 3rd most common gastrointestinal diagnosis with nearly 4 million scheduled or emergency visits. In France, self-reported questionnaires estimate that one person in five has suffered at least one hemorrhoidal attack in the past year.

Detailed description: Hemorrhoidal disease significantly alters the quality of life, can be life threatening in case of heavy bleeding and has a significant economic impact.

However, there are still many unknowns regarding the different types of hemorrhoidal disease, its symptoms, its natural history, its etiology, its triggering and promoting factors, the associated pathologies, the therapeutic indications, etc.

In addition, the therapeutic management is not consensual, especially since the therapeutic arsenal is constantly expanding over the last 20 years with the advent of minimally invasive surgical techniques.

The aim of the work is to answer some of these questions on the basis of a prospective cohort of patients.

Eligibility criteria: Inclusion Criteria:

* Patient whose age is ≥ 18 years
* Consecutive patients consulting for hemorrhoidal disease at the proctology department of the Groupe Hospitalier Paris Saint-Joseph (GHPSJ) between January 1, 2020 and April 30, 2020
* French-speaking patient

Exclusion Criteria:

* Patient objecting to participation in the study
* Patient under guardianship or curatorship
* Patient deprived of liberty
* Patient under court protection

Primary outcomes:
measure: Evaluate the effectiveness of the different treatments proposed according to the type of hemorrhoidal disease (internal, external or both)
timeFrame: 6 months
measure: Evaluate the effectiveness of the different treatments proposed according to the type of hemorrhoidal disease (internal, external or both)
timeFrame: 6 months
measure: Evaluate the effectiveness of the different treatments proposed according to the type of hemorrhoidal disease (internal, external or both)
timeFrame: 6 months
Secondary outcomes:
measure: Evaluate the proportion of patients consulting for hemorrhoidal disease in the general proctology consultation of a specialized center that also receives emergencies
timeFrame: 6 months
measure: Describe the various symptoms of hemorrhoidal disease
timeFrame: 6 months
measure: Search for proctological pathologies associated with hemorrhoidal disease
timeFrame: 6 months
measure: Determine potential risk factors for hemorrhoidal disease
timeFrame: 6 months
Other outcomes:
Locations:
city: Paris
country: France
facility: Groupe Hospitalier Paris Saint Joseph
state: Ile-de-France
Study officials:
References: